Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeloma: use of "progression-free survival 2" as a clinical trial end-point

Meletios Α. Dimopoulos, A. Palumbo, Robin Foà et al.|Haematologica|2015

Cited by 30